Zhejiang Doer Biologics Co., Ltd.

This study tests an investigational drug called DR10624 in 110 adults with fatty liver disease (MASLD) who are at high risk for liver scarring (fibrosis). The goal is to see if the drug can safely reduce liver fat and stiffness compared to a placebo. Participants receive injectio…